Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PLAU antibody (AA 179-431)

This Rabbit Polyclonal antibody specifically detects PLAU in WB and ELISA. It exhibits reactivity toward Human, Mouse and Ratand has been mentioned in 1 publication.
Catalog No. ABIN5692920

Quick Overview for PLAU antibody (AA 179-431) (ABIN5692920)

Target

See all PLAU Antibodies
PLAU (Plasminogen Activator, Urokinase (PLAU))

Reactivity

  • 86
  • 28
  • 21
  • 7
  • 5
  • 5
  • 3
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 86
  • 20
  • 12
  • 5
  • 1
  • 1
Rabbit

Clonality

  • 90
  • 31
  • 2
Polyclonal

Conjugate

  • 77
  • 15
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This PLAU antibody is un-conjugated

Application

  • 87
  • 56
  • 52
  • 27
  • 26
  • 16
  • 12
  • 11
  • 10
  • 9
  • 6
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 7
    • 6
    • 6
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 179-431

    Purpose

    Anti-PLAU Antibody Picoband®

    Cross-Reactivity (Details)

    No cross-reactivity with other proteins.

    Characteristics

    Anti-PLAU Antibody Picoband® (ABIN5692920). Tested in ELISA, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

    Immunogen

    E. coli-derived human PLAU recombinant protein (Position: I179-L431).

    Isotype

    IgG
  • Application Notes

    Western blot, 0.1-0.5 μg/mL
    ELISA, 0.1-0.5 μg/mL
    1. Degryse, Bernard (1 June 2011). "The urokinase receptor system as strategic therapeutic target: challenges for the 21st century". Current Pharmaceutical Design. 17 (19): 1872-1873. 2. Tang, Linlin, Han, Xiuzhen (March 2013). "The urokinase plasminogen activator system in breast cancer invasion and metastasis". Biomedicine & Pharmacotherapy. 67 (2): 179-182.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Concentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
  • Wu, Li, Liu, Ning, Li: "Effects of Guiyuanfang and autologous transplantation of bone marrow stem cells on rats with liver fibrosis." in: World journal of gastroenterology, Vol. 11, Issue 8, pp. 1155-60, (2005) (PubMed).

  • Target

    PLAU (Plasminogen Activator, Urokinase (PLAU))

    Alternative Name

    PLAU

    Background

    Synonyms: Urokinase-type plasminogen activator, U-plasminogen activator, uPA, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU

    Tissue Specificity: Expressed in the prostate gland and prostate cancers.

    Background: Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

    Molecular Weight

    48 kDa

    Gene ID

    5328

    UniProt

    P00749

    Pathways

    Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
You are here:
Chat with us!